Form 4: Sarepta Therapeutics Director Sells Shares to Cover Tax Obligations

Kathryn Jean Boor, a director at Sarepta Therapeutics, sold 1,636 shares of common stock to cover taxes related to vesting restricted stock units.

Summary

• Kathryn Jean Boor, a director at Sarepta Therapeutics, sold 1,636 shares of common stock on December 5, 2024.
• The sale was executed at a price of $125.55 per share.
• This transaction was made to generate cash for the payment of taxes due as a result of the vesting of certain restricted stock unit awards.
• Following the transaction, Ms. Boor directly owns 5,880 shares of Sarepta Therapeutics common stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes and does not indicate any positive or negative sentiment towards the company's performance or future prospects.

Industry Context

This is a routine transaction for a company director to sell shares to cover tax obligations related to vesting equity awards. It is a common practice and does not necessarily indicate a change in the director's outlook on the company.

Comparison to Industry Standards

• Sales of shares by directors to cover tax obligations are a common practice across the industry.
• Many directors of publicly traded companies use similar strategies to manage their personal finances and tax liabilities related to equity compensation.
• The sale of 1,636 shares is not unusual for a director's transaction and is within the typical range of such sales.

Stakeholder Impact

• The sale of shares by a director may have a minor impact on the stock price, but it is generally not considered a significant event.

Key Dates

Keywords

Sarepta Therapeutics, insider trading, stock sale, Kathryn Jean Boor, Form 4, director, restricted stock units, tax obligations